-+ 0.00%
-+ 0.00%
-+ 0.00%

Zoetis Exec Says New U.S. Dermatology Competitor Has Had Limited Share Gains Due To Supply Challenges; Expects Third-To-/Fourth Quarter Revenue Decline In High Single-Digit Range, Partly Due To Third-quarter Promotional Activity

Benzinga·11/05/2026 14:24:06

-Conference Call.